Early stage IT and Healthcare Investing

Indi Molecular

portfoliocompanies

company snapshot

Indi Molecular

Indi Molecular is an emerging life sciences company that is developing a synthetic class of diagnostic and therapeutic agents with antibody-like properties: protein-catalyzed capture agents. PCCs were created in collaboration with the California Institute of Technology using “click chemistry,” a synthetic process that allows scientists to permanently join (“click”) together molecular components with remarkable precision and stability.

Investment Team
Albert Luderer, CEO
Facebook Google+ Twitter Email LinkedIn Share